Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NeuBase Therapeutics, Inc. | Chief Operating Officer | Common stock | 11.2K | $21.5K | $1.92 | Mar 30, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NBSE | NeuBase Therapeutics, Inc. | Mar 30, 2022 | 1 | $11.9K | 4 | Apr 1, 2022 | Chief Operating Officer |
NBSE | NeuBase Therapeutics, Inc. | Jan 24, 2022 | 1 | $0 | 4 | Jan 25, 2022 | Chief Operating Officer |
NBSE | NeuBase Therapeutics, Inc. | Aug 16, 2021 | 1 | $0 | 4 | Sep 24, 2021 | COO |